Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6895451 | 0.81 | IDO1 (0.47) | POLBAAK1HRH3CACNA1HCYP1A2 | |
| SCHEMBL12719559 | 0.78 | IDO1 (0.53) | POLBHRH3CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1255527 | 0.76 | CACNA1H (0.43) | POLBAAK1HRH3CACNA1HIDO1 | |
| Hydrochloric Acid SCHEMBL1512918 | 0.75 | CACNA1H (0.42) | POLBAAK1HRH3CACNA1HIDO1 | |
| SCHEMBL1255702 | 0.74 | IDO1 (0.55) | POLBHRH3IDO1 | |
| SCHEMBL6670417 | 0.74 | IDO1 (0.55) | POLBHRH3IDO1 | |
| SCHEMBL6893944 | 0.73 | POLB (0.34) | POLBAAK1HRH3CACNA1HCYP1A2 | |
| SCHEMBL7649873 | 0.72 | TDP1 (0.47) | POLBKDM4E | |
| SCHEMBL1257016 | 0.72 | CACNA1H (0.44) | AAK1CACNA1HCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1256793 | 0.69 | POLB (0.41) | POLBHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011031816-A2 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | SEPRACOR INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011031818-A2 | HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF | SEPRACOR INC. (US) | 2011-03-17 | — | — | WO | disclosed |